Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estradiol cipionate/medroxyprogesterone - Pfizer

Drug Profile

Estradiol cipionate/medroxyprogesterone - Pfizer

Alternative Names: Cyclofem; CycloProvera™; Esprova™; Estradiol cypionate/medroxyprogesterone - Pharmacia; Lunella; Lunelle™; MPA/E2C

Latest Information Update: 05 Feb 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Estradiol congeners; Estrenes; Injectable contraceptives
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 05 Feb 2015 Launched for Contraception/Pregnancy (Prevention) in Argentina and Hong Kong (IM) before February 2015
  • 05 Feb 2015 Withdrawn for Contraception/Pregnancy (Prevention) in USA, Chile and Indonesia (IM) before February 2015
  • 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top